Literature DB >> 21073074

G6PD enzyme activity in normal term Malaysian neonates and adults using a OSMMR2000-D kit with Hb normalization.

R Z Azma1, N Hidayati, N R Farisah, N H Hamidah, O Ainoon.   

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is one of the commonest causes of neonatal jaundice in Malaysia. Screening of cord blood for G6PD deficiency by the semiquantitative fluorescent spot test (FST) is performed in Malaysia but this test can miss cases of partial G6PD deficiency. The OSMMR-D kit assay measures G6PD activity and hemoglobin (Hb) concentration, allowing direct expression of results in U/gHb. We evaluated this method and established the normal range for G6PD activity in normal term neonates and adults. EDTA blood from 94 neonates and 295 adults (age 15-59 years old) with normal Hb and FST were selected. The normal means for G6PD activity for neonates and adults were 12.43 +/- 2.28 U/gHb and 9.21 +/- 2.6 U/gHb, respectively; the reference ranges for normal G6PD activity in neonates and adults were 10.15-14.71 U/gHb and 6.61-11.81 U/gHb respectively. There were no significant differences in mean normal G6PD activity between the Malays and Chinese racial groups or between genders. The upper and lower limit cut-off points for partial deficiency in neonates were 7.4 U/gHb (60% of the normal mean) and 2.5 U/gHb (20% of the normal mean), respectively. For adults, the upper and lower limit cut-off points for partial deficiency in adults were 5.52 U/gHb (60% of the normal mean) and 1.84 U/gHb (20% of the normal mean), respectively. The quantitation of G6PD enzymes using this OSMMR-D kit with Hb normalization was simple since the Hb was analyzed simultaneously and the results were reproducible with a CV of less than 5%.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21073074

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  5 in total

1.  Evaluation of Glucose-6-Phosphate Dehydrogenase stability in stored blood samples.

Authors:  Norunaluwar Jalil; Raja Zahratul Azma; Emida Mohamed; Azlin Ithnin; Hafiza Alauddin; Siti Noor Baya; Ainoon Othman
Journal:  EXCLI J       Date:  2016-02-19       Impact factor: 4.068

Review 2.  Glucose-6-Phosphate Dehydrogenase Deficiency and Neonatal Hyperbilirubinemia: Insights on Pathophysiology, Diagnosis, and Gene Variants in Disease Heterogeneity.

Authors:  Heng Yang Lee; Azlin Ithnin; Raja Zahratul Azma; Ainoon Othman; Armindo Salvador; Fook Choe Cheah
Journal:  Front Pediatr       Date:  2022-05-24       Impact factor: 3.569

3.  Lower reference limits of quantitative cord glucose-6-phosphate dehydrogenase estimated from healthy term neonates according to the Clinical and Laboratory Standards Institute guidelines: a cross sectional retrospective study.

Authors:  Sameer Yaseen Al-Abdi; Amina Suleman Alsaigh; Fahima Lugman Aldawoud; Amal Ali Al Sadiq
Journal:  BMC Pediatr       Date:  2013-09-10       Impact factor: 2.125

4.  Genetic and Epigenetic Factors Co-Influence the Severity of Phenotypic Presentations in Compound G6PD Mutations

Authors:  Yee Yik Mot; Jay Suriar Rajasuriar; Hafizuddin Mohamed Fauzi; Emmanuel Jairaj Moses; Narazah Mohd Yusoff
Journal:  Turk J Haematol       Date:  2021-12-10       Impact factor: 1.831

5.  Genotyping of Malaysian G6PD-deficient neonates by reverse dot blot flow-through hybridisation.

Authors:  M F Alina; R Z Azma; J Norunaluwar; I Azlin; A J Darnina; F C Cheah; A R Noor-Farisah; A A Siti-Hawa; X R K Danny; Noor-Fadzilah Zulkifli; O Ainoon
Journal:  J Hum Genet       Date:  2019-12-20       Impact factor: 3.172

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.